<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni,Bold" color="#000000"/>
	<fontspec id="font6" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font7" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font9" size="8" family="SymbolMT" color="#000000"/>
<text top="41" left="55" width="192" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">World Journal of Emergency Surgery 2007, 2 :13<i>World Journal of Emergency Surgery</i></text>
<text top="41" left="417" width="137" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.wjes.org/content/2/1/13</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="123" segment_no="15" tag_type="text">Page 4 of 6<b>2</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="124" segment_no="16" tag_type="text">(page number not for citation purposes)</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="43" segment_no="4" tag_type="text">In spite of this, EPO did not have a significant effect on</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="44" segment_no="4" tag_type="text">anastomosis which was performed without obstruction in</text>
<text top="239" left="55" width="142" height="9" font="font4" id="p1_t7" reading_order_no="45" segment_no="4" tag_type="text">respect to fibroblast proliferation.<i>(page number not for citation purposes)</i></text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="46" segment_no="6" tag_type="text">Although the storage of collagen was equal and higher in</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="47" segment_no="6" tag_type="text">groups in which EPO was given (Group III and Group IV),</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="48" segment_no="6" tag_type="text">when compared to the control group, there was no signif-</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="49" segment_no="6" tag_type="text">icant difference (p &gt; 0.05) . In contrast, when Group III</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="50" segment_no="6" tag_type="text">and Group IV were compared with Group II which had</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="51" segment_no="6" tag_type="text">the lowest storage of collagen, the difference was signifi-</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="52" segment_no="6" tag_type="text">cant (p = 0.02) . In this case, it was observed that the</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="53" segment_no="6" tag_type="text">decreased storage of collagen after resection increased<b>(p &gt; 0.05)</b></text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="54" segment_no="6" tag_type="text">positively with the administration of EPO and it was sig-</text>
<text top="369" left="55" width="140" height="9" font="font4" id="p1_t17" reading_order_no="55" segment_no="6" tag_type="text">nificant in the obstruction group.</text>
<text top="392" left="55" width="134" height="10" font="font6" id="p1_t18" reading_order_no="56" segment_no="8" tag_type="title">Discussion and conclusions</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="57" segment_no="9" tag_type="text">Insufficiency of intestinal anastomosis remains the most</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="58" segment_no="9" tag_type="text">important cause of morbidity and mortality after gastroin-<b>(p = 0.02)</b></text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="59" segment_no="9" tag_type="text">testinal tract surgery. Despite the increased risk of leakage</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="60" segment_no="9" tag_type="text">after emergency procedure at all sides of the intestine, the</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="61" segment_no="9" tag_type="text">occurrence of anastomotic leakage appears more fre-</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="62" segment_no="9" tag_type="text">quently during colonic operations with high morbidity</text>
<text top="474" left="55" width="60" height="9" font="font4" id="p1_t25" reading_order_no="63" segment_no="9" tag_type="text">and mortality.<b>Discussion and conclusions</b></text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="64" segment_no="10" tag_type="text">Various factors have been shown to effect healing of anas-</text>
<text top="510" left="55" width="59" height="9" font="font4" id="p1_t27" reading_order_no="65" segment_no="10" tag_type="text">tomosis [1-3].</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="66" segment_no="12" tag_type="text">One of the growth factors thought to have a positive effect</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="67" segment_no="12" tag_type="text">on the wound healing process is erythropoietin which is a</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="68" segment_no="12" tag_type="text">haematopoietic growth factor. Erythropoietin(EPO) is a</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="69" segment_no="12" tag_type="text">glycoprotein with a true hormonal structure which is</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="70" segment_no="12" tag_type="text">located in the alpha-globulin fraction of the plasma and</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="71" segment_no="12" tag_type="text">has a molecular weight of 46.000 kilodaltons. Like growth</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="72" segment_no="12" tag_type="text">hormone(GH), it is also a member of the hematopoietic<a href="">mosis [1-3].</a></text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="73" segment_no="12" tag_type="text">super family which consists of GH, EPO, granulocyte and</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="74" segment_no="12" tag_type="text">macrophage colony-stimulating factor, interleukin 3 [IL-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="75" segment_no="12" tag_type="text">3], IL-4, IL-6, IL-7. All of them have similarities in their</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="76" segment_no="12" tag_type="text">receptor structure [16,17]. It is likely that cross-reactivity</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="77" segment_no="12" tag_type="text">between certain growth factors may exist. EPO is pro-</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="78" segment_no="12" tag_type="text">duced mainly in the kidneys and to a lesser extent in the</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="79" segment_no="12" tag_type="text">liver [18]. Circulating EPO binds to EPO receptors on the</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="80" segment_no="12" tag_type="text">surface of erythroid progenitors resulting in the replica-</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="81" segment_no="12" tag_type="text">tion and maturation to functional erythrocytes [19]. In</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="82" segment_no="12" tag_type="text">studies, its receptors have also been found in the kidneys,</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="83" segment_no="5" tag_type="text">liver, brain, the intestines, bone marrow and cardiomy-<a href="">ructure [16,17]</a>. It is likely that cross-reactivity</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="84" segment_no="5" tag_type="text">osites [5-10,20,21]. It also shows an anabolic effect on</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="85" segment_no="5" tag_type="text">wound healing by affecting other growth factor receptors</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="86" segment_no="5" tag_type="text">thus increasing fibroblast proliferation, collagen deposi-<a href="">er [18</a>]. Circulating EPO binds to EPO receptors on the</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="87" segment_no="5" tag_type="text">tion, endothelial cell proliferation (angiogenesis) and the</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="88" segment_no="5" tag_type="text">manufacture of extracellular matrixes. It also has a trophic<a href="">ytes [19</a>]. In</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="89" segment_no="5" tag_type="text">affect on gastrointestinal growth and development and</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="90" segment_no="5" tag_type="text">increases cell turnover and cell migration [8]. Recom-</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="91" segment_no="5" tag_type="text">binant EPO has also been used in patients awaiting elec-<a href="">osites [5-10,20,21</a>]. It also shows an anabolic effect on</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="92" segment_no="5" tag_type="text">tive surgery to increase their packed red blood cell volume</text>
<text top="333" left="313" width="20" height="9" font="font4" id="p1_t55" reading_order_no="93" segment_no="5" tag_type="text">[22].</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="94" segment_no="7" tag_type="text">In an experimental study which was done by Fatouros that</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="95" segment_no="7" tag_type="text">examines the effect of EPO on colonic anastomose heal-</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="96" segment_no="7" tag_type="text">ing, it has been established that, among the rats which</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="97" segment_no="7" tag_type="text">were given EPO for 15 days preoperatively and 7 days<a href=""> [8</a>]. Recom-</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="98" segment_no="7" tag_type="text">postoperatively, the breaking strength of primary left</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="99" segment_no="7" tag_type="text">colonic anastomosis increased by 37% [9,10]. In histolog-</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="100" segment_no="7" tag_type="text">ical examination on the anostomotic area, a smaller<a href="">[22</a>].</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="101" segment_no="7" tag_type="text">number of inflammatory cells have been observed in the</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="102" segment_no="7" tag_type="text">EPO group, when compared to the control group. Despite</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="103" segment_no="7" tag_type="text">this, more fibroblast reaction and angiogenesis was</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="104" segment_no="7" tag_type="text">observed in the EPO group when compared to the control</text>
<text top="486" left="313" width="27" height="9" font="font4" id="p1_t67" reading_order_no="105" segment_no="7" tag_type="text">group.</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="106" segment_no="11" tag_type="text">In order to investigate the effect of EPO on wound healing<a href="">9,10]. In histolo</a>g-</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="107" segment_no="11" tag_type="text">in resection and anastomosis after colonic obstruction, a</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="108" segment_no="11" tag_type="text">new group was added and EPO administration was</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="109" segment_no="11" tag_type="text">applied for 7 days postoperatively. The healing of anasto-</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="110" segment_no="11" tag_type="text">mosis was evaluated by using mechanical bursting pres-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="111" segment_no="11" tag_type="text">sure measurement, the tissue hydroxyproline level, and</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="112" segment_no="11" tag_type="text">the collagen storage score during histological examina-</text>
<text top="592" left="313" width="20" height="9" font="font4" id="p1_t75" reading_order_no="113" segment_no="11" tag_type="text">tion.</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="114" segment_no="13" tag_type="text">Although tissue hydroxyproline and bursting pressure lev-</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="115" segment_no="13" tag_type="text">els in Group III were both higher than the control group</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="116" segment_no="13" tag_type="text">no significant difference was found in groups without</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="117" segment_no="13" tag_type="text">obstruction. Using these results we might say that EPO</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="118" segment_no="13" tag_type="text">could have positive beneficial effects after primary left</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="119" segment_no="13" tag_type="text">colonic anastomosis however, in comparison to Fatouros'</text>
<text top="686" left="313" width="184" height="9" font="font4" id="p1_t82" reading_order_no="120" segment_no="13" tag_type="text">study this improvement was not significant.</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="121" segment_no="14" tag_type="text">The results of the histological evaluation show that the</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="122" segment_no="14" tag_type="text">histological inflammation score of the groups in which</text>
<text top="87" left="55" width="218" height="7" font="font7" id="p1_t85" reading_order_no="2" segment_no="2" tag_type="title">Table 2: Mean(SEM) values of the parameters in all groups</text>
<text top="105" left="59" width="28" height="7" font="font7" id="p1_t86" reading_order_no="3" segment_no="3" tag_type="table">Groups</text>
<text top="105" left="254" width="32" height="7" font="font7" id="p1_t87" reading_order_no="4" segment_no="3" tag_type="table">Group 1</text>
<text top="105" left="325" width="32" height="7" font="font7" id="p1_t88" reading_order_no="5" segment_no="3" tag_type="table">Group 2</text>
<text top="105" left="404" width="32" height="7" font="font7" id="p1_t89" reading_order_no="6" segment_no="3" tag_type="table">Group 3</text>
<text top="105" left="480" width="32" height="7" font="font7" id="p1_t90" reading_order_no="7" segment_no="3" tag_type="table">Group 4</text>
<text top="127" left="59" width="73" height="7" font="font7" id="p1_t91" reading_order_no="8" segment_no="3" tag_type="table">No of nonsurvivors</text>
<text top="127" left="254" width="4" height="7" font="font8" id="p1_t92" reading_order_no="9" segment_no="3" tag_type="table">2<b>Table 2: Mean(SEM) values of the parameters in all groups</b></text>
<text top="127" left="325" width="4" height="7" font="font8" id="p1_t93" reading_order_no="10" segment_no="3" tag_type="table">1<b>Groups</b></text>
<text top="127" left="404" width="4" height="7" font="font8" id="p1_t94" reading_order_no="11" segment_no="3" tag_type="table">1<b>Group 1</b></text>
<text top="127" left="480" width="4" height="7" font="font8" id="p1_t95" reading_order_no="12" segment_no="3" tag_type="table">3<b>Group 2</b></text>
<text top="137" left="59" width="104" height="7" font="font7" id="p1_t96" reading_order_no="13" segment_no="3" tag_type="table">Bursting Pressure (mmHg)<b>Group 3</b></text>
<text top="137" left="254" width="34" height="7" font="font8" id="p1_t97" reading_order_no="14" segment_no="3" tag_type="table">200 (5.00)<b>Group 4</b></text>
<text top="137" left="325" width="40" height="7" font="font8" id="p1_t98" reading_order_no="15" segment_no="3" tag_type="table">176.6 (2.30)<b>No of nonsurvivors</b></text>
<text top="137" left="404" width="38" height="7" font="font8" id="p1_t99" reading_order_no="16" segment_no="3" tag_type="table">205 (15.23)</text>
<text top="137" left="480" width="40" height="7" font="font8" id="p1_t100" reading_order_no="17" segment_no="3" tag_type="table">198.6 (2.19)</text>
<text top="145" left="59" width="113" height="10" font="font7" id="p1_t101" reading_order_no="18" segment_no="3" tag_type="table">Hydroxyproline level ( μ g/mg)</text>
<text top="148" left="254" width="36" height="7" font="font8" id="p1_t102" reading_order_no="19" segment_no="3" tag_type="table">1.74 (0.19)</text>
<text top="148" left="325" width="36" height="7" font="font8" id="p1_t103" reading_order_no="20" segment_no="3" tag_type="table">1.63 (0.27)<b>Bursting Pressure (mmHg)</b></text>
<text top="148" left="404" width="36" height="7" font="font8" id="p1_t104" reading_order_no="21" segment_no="3" tag_type="table">1.91 (0.40)</text>
<text top="148" left="480" width="36" height="7" font="font8" id="p1_t105" reading_order_no="22" segment_no="3" tag_type="table">2.52 (0.40)</text>
<text top="158" left="59" width="52" height="7" font="font7" id="p1_t106" reading_order_no="23" segment_no="3" tag_type="table">Inflammation</text>
<text top="158" left="254" width="28" height="7" font="font8" id="p1_t107" reading_order_no="24" segment_no="3" tag_type="table">2.6 (0.5)</text>
<text top="158" left="325" width="16" height="7" font="font8" id="p1_t108" reading_order_no="25" segment_no="3" tag_type="table">4 (0)<b>Hydroxyproline level (</b></text>
<text top="158" left="404" width="28" height="7" font="font8" id="p1_t109" reading_order_no="26" segment_no="3" tag_type="table">3.5 (0.7)</text>
<text top="158" left="480" width="28" height="7" font="font8" id="p1_t110" reading_order_no="27" segment_no="3" tag_type="table">3.8 (0.4)<b>g/mg)</b></text>
<text top="168" left="59" width="74" height="7" font="font7" id="p1_t111" reading_order_no="28" segment_no="3" tag_type="table">Neovascularization</text>
<text top="168" left="254" width="16" height="7" font="font8" id="p1_t112" reading_order_no="29" segment_no="3" tag_type="table">2 (0)</text>
<text top="168" left="325" width="28" height="7" font="font8" id="p1_t113" reading_order_no="30" segment_no="3" tag_type="table">1.6 (0.5)</text>
<text top="168" left="404" width="28" height="7" font="font8" id="p1_t114" reading_order_no="31" segment_no="3" tag_type="table">3.8 (0.4)</text>
<text top="168" left="480" width="28" height="7" font="font8" id="p1_t115" reading_order_no="32" segment_no="3" tag_type="table">2.6 (0.5)<b>Inflammation</b></text>
<text top="178" left="59" width="76" height="7" font="font7" id="p1_t116" reading_order_no="33" segment_no="3" tag_type="table">Fibroblast ingrowth</text>
<text top="178" left="254" width="16" height="7" font="font8" id="p1_t117" reading_order_no="34" segment_no="3" tag_type="table">4 (0)</text>
<text top="178" left="325" width="28" height="7" font="font8" id="p1_t118" reading_order_no="35" segment_no="3" tag_type="table">1.8 (0.8)</text>
<text top="178" left="404" width="15" height="7" font="font8" id="p1_t119" reading_order_no="36" segment_no="3" tag_type="table">4.(0)</text>
<text top="178" left="480" width="28" height="7" font="font8" id="p1_t120" reading_order_no="37" segment_no="3" tag_type="table">3.8 (0.4)<b>Neovascularization</b></text>
<text top="189" left="59" width="78" height="7" font="font7" id="p1_t121" reading_order_no="38" segment_no="3" tag_type="table">Collagen Deposition</text>
<text top="189" left="254" width="16" height="7" font="font8" id="p1_t122" reading_order_no="39" segment_no="3" tag_type="table">2 (0)</text>
<text top="189" left="325" width="28" height="7" font="font8" id="p1_t123" reading_order_no="40" segment_no="3" tag_type="table">1.8 (0.4)</text>
<text top="189" left="404" width="28" height="7" font="font8" id="p1_t124" reading_order_no="41" segment_no="3" tag_type="table">2.6 (0.5)</text>
<text top="189" left="480" width="29" height="7" font="font8" id="p1_t125" reading_order_no="42" segment_no="3" tag_type="table">2.6 80.5)<b>Fibroblast ingrowth</b></text>
</page>
</pdf2xml>
